External Pacemakers Market Report: Market Size & Forecast 2026

External pacemakers represent a critical segment within the broader cardiac rhythm management device market, encompassing devices used both temporarily and permanently to correct abnormal heart rhythms. The $1.9 billion global market size in 2025 reflects sustained demand for these life-sustaining devices across hospital and ambulatory care settings. Growth at 3.4% annually is steady, reflecting mature markets in developed regions balanced by expanding access in emerging economies.

• •Market valued at approximately $1.9 billion in 2025
• •Expected CAGR of 3.4% through the forecast period
• •Includes both temporary external pacing systems and implantable devices

The primary catalyst for market expansion is the rising global burden of cardiovascular diseases, particularly arrhythmias, coupled with demographic shifts toward older populations who face higher rates of heart rhythm disorders. Increased procedural volumes in electrophysiology, alongside improved awareness and diagnosis of cardiac conduction disorders, are expanding the patient pool eligible for pacing therapy. Technological advancements in battery life, device miniaturization, and MRI-conditional pacemakers also drive replacement cycles and upgrade adoption.

• •Aging global population increases prevalence of bradycardia and arrhythmias
• •Growing number of cardiac procedures and electrophysiology interventions worldwide
• •Technological improvements including MRI-compatible and leadless designs

The market is segmented by product type, including single-chamber, dual-chamber, and biventricular pacemakers, as well as by end-user setting such as hospitals, cardiac centers, and ambulatory surgical facilities. Geographically, North America holds the largest market share due to advanced healthcare infrastructure and high device adoption rates, while Europe follows closely behind. The Asia-Pacific region is the fastest-growing segment, driven by improving healthcare access, rising medical tourism, and increasing prevalence of lifestyle-related cardiac conditions in countries such as China and India.

• •North America leads in market share; Asia-Pacific is the fastest-growing region
• •Segmentation by chamber type: single-chamber, dual-chamber, and cardiac resynchronization therapy devices
• •Hospitals and specialty cardiac centers remain dominant distribution channels

What are the recent trends and outlook?

Key trends shaping the market include the transition toward leadless and subcutaneous pacing systems, which reduce complication risks associated with traditional transvenous leads. Remote device monitoring and integration with telehealth platforms are gaining prominence, enabling proactive patient management and reducing hospital readmissions. Looking forward, the market is expected to maintain its 3.4% growth trajectory as emerging markets expand cardiac care infrastructure, and as next-generation technologies such as autonomous pacing algorithms and longer-lasting batteries enter commercial use.

• •Rising adoption of leadless and MRI-conditional pacemaker technologies
• •Remote monitoring and telehealth integration becoming standard features
• •Emerging market expansion and reimbursement policy improvements support long-term growth